Correction: MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window

Other OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-21 ⓘ

This correction paper addresses the finding that microRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal or mild endometriosis during the implantation window.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-09 · read from full text ⓘ

This document is a formal correction notice issued by the publisher of PLoS ONE to address an error in Figure 4 of a previously published article. The original study, titled "MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window," was republished on August 10, 2020, to provide the correct version of the data visualization. The notice serves solely to inform readers of the discrepancy and apologize for the mistake, without presenting new scientific findings or altering the core conclusions of the research. Relevance to endometriosis: Centrally about the condition, specifically investigating molecular mechanisms in infertile women with minimal to mild endometriosis during the implantation window.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0234086.].
Full text 1,179 characters · extracted from oa-doi-fallback · click to expand
Notice of republication An incorrect version of Fig 4 was published in error. The publisher apologizes for this error. This article was republished on August 10, 2020, to correct for this error. Please download this article again to view the correct version. Reference - 1. Xiao L, Pei T, Huang W, Zhou M, Fu J, Tan J, et al. (2020) MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window. PLoS ONE 15(7): e0234086. https://doi.org/10.1371/journal.pone.0234086 pmid:32658928 Citation: The PLOS ONE Staff (2020) Correction: MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window. PLoS ONE 15(8): e0238656. https://doi.org/10.1371/journal.pone.0238656 Published: August 28, 2020 Copyright: © 2020 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (1)

Source provenance

europepmc
last seen: 2026-11-06T06:14:58.568748+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:28:22.610273+00:00
License: CC0 · commercial use OK